Peptide Therapy

Moderate Evidence

BPC-157

Gastric pentadecapeptide for tissue repair, angiogenesis, and gastrointestinal healing.

12 articles · 105 min total
01

FDA 2026 Peptide Reclassification: What the Category 1 Compounding Ruling Means for Patients

The FDA's 2026 action returns roughly 14 peptides to Category 1 compounding eligibility. A physician explains what changed, which peptides are affected, and what this means for your access.

FDA 2026 Peptide Reclassification: What the Category 1 Compounding Ruling Means for Patients
02

Peptides for Autoimmune Disease: A Physician's Evidence-Based Guide

Discover how immunomodulatory peptides like Thymosin Alpha-1, BPC-157, and LL-37 can help regulate immune dysfunction in autoimmune conditions. Clinical protocols and evidence.

Peptides for Autoimmune Disease: A Physician's Evidence-Based Guide
03

Peptide Stacking: A Physician's Guide to Combining BPC-157, TB-500, and GHK-Cu

Learn how to safely combine therapeutic peptides like BPC-157, TB-500, and GHK-Cu for synergistic healing, with dosing protocols and clinical evidence.

Peptide Stacking: A Physician's Guide to Combining BPC-157, TB-500, and GHK-Cu
04

Peptide Therapy Benefits: A Physician's Evidence-Based Overview

Dr. Douwes reviews the clinically relevant benefits of peptide therapy — from tissue repair and immune modulation to longevity and brain health. What evidence supports each claim.

Peptide Therapy Benefits: A Physician's Evidence-Based Overview
05

Best Peptides for Healing: A Physician's Ranked Guide to Tissue Repair

Dr. Julian Douwes ranks the most effective peptides for tissue repair, wound healing, and recovery — with dosing context and evidence grades for each.

Best Peptides for Healing: A Physician's Ranked Guide to Tissue Repair
06

BPC-157 Oral vs Injection: Which Route Delivers Better Results?

Physician comparison of BPC-157 oral capsules versus subcutaneous injection — covering bioavailability, onset, dosing, and clinical use cases for each route.

BPC-157 Oral vs Injection: Which Route Delivers Better Results?
07

Peptide Therapy for Women: What the Clinical Evidence Actually Shows

A physician's evidence-based guide to peptide therapy for women — covering hormonal interactions, key peptides, dosing considerations, and who is a suitable candidate.

Peptide Therapy for Women: What the Clinical Evidence Actually Shows
08

BPC-157 Side Effects: What Patients Actually Report

Honest physician assessment of BPC-157 side effects, contraindications, FDA status, and what patients report. Evidence levels clearly distinguished.

BPC-157 Side Effects: What Patients Actually Report
09

BPC-157 Side Effects: What the Evidence Actually Shows

Honest assessment of BPC-157 side effects, safety data, FDA warnings, and theoretical risks. What we know, what we don't, and what to watch for.

BPC-157 Side Effects: What the Evidence Actually Shows
10

BPC-157 Dosage Guide: Subcutaneous, Oral, and Injection Protocols

Evidence-based BPC-157 dosing protocols. Subcutaneous vs oral routes, loading vs maintenance, body weight calculations, and clinical observations.

BPC-157 Dosage Guide: Subcutaneous, Oral, and Injection Protocols
11

BPC-157 vs TB-500: Which Peptide for Tissue Repair?

A clinical comparison of BPC-157 and TB-500 for tissue repair. Mechanisms, evidence quality, best use cases, combination protocols, and what I observe in practice.

BPC-157 vs TB-500: Which Peptide for Tissue Repair?
12

BPC-157: What the Research Actually Shows

Honest physician's assessment of BPC-157 peptide. Mechanisms, animal vs human evidence, dosing, safety, and clinical observations from Dr. Julian Douwes.

BPC-157: What the Research Actually Shows
← Back to Peptide Therapy